investigational disclaimer

about our investigational programmes

Kode Immunoeducers are investigational. Please read this before relying on anything on this website.

Investigational disclaimer: what this means

Investigational products

Kode Immunoeducers (KIEs), including AGI-134, K5K and Kv9, are investigational. None has been approved by any medicines or veterinary regulator for sale or for treating patients or animals.

  • AGI-134: Phase 1/2a experience in 38 late-stage human patients. Clinical efficacy remains unproven.
  • K5K: an investigational human-development candidate. Safety and efficacy have not yet been established in humans.
  • Kv9: in veterinary development. Preliminary canine experience provides translational evidence only and cannot establish human K5K outcomes.

Not medical advice

Information on this website is for general information only. It is not medical or veterinary advice, a recommendation for treatment, or an offer of treatment. Kode Biotech does not provide medical treatment. If you have questions about your health or your animal's health, talk to a qualified health or veterinary professional.

Forward-looking statements

Some statements on this website describe plans, goals and expectations, such as development programmes, trials and intended effects. They are not guarantees. Research results, regulatory decisions, funding and other factors may mean that outcomes differ.

Third-party content

Media articles in our news archive are kept as published at the time and are not endorsed.

Questions

Contact us at [email protected].